PDMR dealing

 19th Dec 2018

Download the full announcement

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-traded medical diagnostics business, announces that on 19 December 2018, the Company was notified by Mike Salter (President, Americas) that he has today purchased 125,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares").

 

EKF Diagnostics Holdings plc
Christopher Mills, Non-Executive Chairman
Julian Baines, CEO
Richard Evans, FD and COO

www.ekfdiagnostics.com
Tel: 00 44 29 2071 0570
N+1 Singer (Nomad & Broker)

Aubrey Powell / Lauren Kettle / George Tzimas (Corporate Finance)
Tom Salvesen (Corporate Broking)

Tel: 020 7496 3000

Walbrook PR Limited
Paul McManus
Lianne Cawthorne

Tel: 020 7933 8780 or
Mob: 07980 541 893 / 07584 391 303
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mike Salter

2

Reason for the notification

a)

Position/status

President, Americas

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

EKF Diagnostics Holdings plc

b)

LEI

213800DXTF3EAUK1AR05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1p each (“Ordinary Shares”)

 

ISIN Code: GB0031509804

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

24.75p

125,000

 

d)

Aggregated information

- Aggregated volume

- Price

n/a

e)

Date of the transaction

19 December 2018

f)

Place of the transaction

London Stock Exchange